Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.
about
The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.Discovery of regulators of receptor internalization with high-throughput flow cytometry.Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
P2860
Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Salmeterol/fluticasone propion ...... obstructive pulmonary disease.
@en
type
label
Salmeterol/fluticasone propion ...... obstructive pulmonary disease.
@en
prefLabel
Salmeterol/fluticasone propion ...... obstructive pulmonary disease.
@en
P2860
P1433
P1476
Salmeterol/fluticasone propion ...... obstructive pulmonary disease.
@en
P2093
Paul L McCormack
P2860
P304
P356
10.2165/00003495-200767160-00006
P577
2007-01-01T00:00:00Z
P6179
1049116478